title: Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia.
abstract: Acyl-CoA:cholesterol acyltransferase (ACAT) catalyzes esterification of cellular cholesterol. To investigate the role of ACAT-1 in atherosclerosis, we have generated ACAT-1 null (ACAT-1-/-) mice. ACAT activities were present in the liver and intestine but were completely absent in adrenal, testes, ovaries, and peritoneal macrophages in our ACAT-1-/- mice. The ACAT-1-/- mice had decreased openings of the eyes because of atrophy of the meibomian glands, a modified form of sebaceous glands normally expressing high ACAT activities. This phenotype is similar to dry eye syndrome in humans. To determine the role of ACAT-1 in atherogenesis, we crossed the ACAT-1-/- mice with mice lacking apolipoprotein (apo) E or the low density lipoprotein receptor (LDLR), hyperlipidemic models susceptible to atherosclerosis. High fat feeding resulted in extensive cutaneous xanthomatosis with loss of hair in both ACAT-1-/-:apo E-/- and ACAT-1-/-:LDLR-/- mice. Free cholesterol content was significantly increased in their skin. Aortic fatty streak lesion size as well as cholesteryl ester content were moderately reduced in both double mutant mice compared with their respective controls. These results indicate that the local inhibition of ACAT activity in tissue macrophages is protective against cholesteryl ester accumulation but causes cutaneous xanthomatosis in mice that lack apo E or LDLR.
authors.affiliation: Departments of Metabolic Diseases, Ophthalmology, Pathology, Faculty of Medicine, University of Tokyo, Hongo, Tokyo 113-8655, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Yagyu
authors.forename: T
authors.initials: T
authors.lastname: Kitamine
authors.forename: J
authors.initials: J
authors.lastname: Osuga
authors.forename: R
authors.initials: R
authors.lastname: Tozawa
authors.forename: Z
authors.initials: Z
authors.lastname: Chen
authors.forename: Y
authors.initials: Y
authors.lastname: Kaji
authors.forename: T
authors.initials: T
authors.lastname: Oka
authors.forename: S
authors.initials: S
authors.lastname: Perrey
authors.forename: Y
authors.initials: Y
authors.lastname: Tamura
authors.forename: K
authors.initials: K
authors.lastname: Ohashi
authors.forename: H
authors.initials: H
authors.lastname: Okazaki
authors.forename: N
authors.initials: N
authors.lastname: Yahagi
authors.forename: F
authors.initials: F
authors.lastname: Shionoiri
authors.forename: Y
authors.initials: Y
authors.lastname: Iizuka
authors.forename: K
authors.initials: K
authors.lastname: Harada
authors.forename: H
authors.initials: H
authors.lastname: Shimano
authors.forename: H
authors.initials: H
authors.lastname: Yamashita
authors.forename: T
authors.initials: T
authors.lastname: Gotoda
authors.forename: N
authors.initials: N
authors.lastname: Yamada
authors.forename: S
authors.initials: S
authors.lastname: Ishibashi
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D001161:Arteriosclerosis / Q000201:enzymology* / Q000235:genetics; D003433:Crosses, Genetic; D015352:Dry Eye Syndromes / Q000201:enzymology* / Q000235:genetics; D005260:Female; D006579:Heterozygote; D006801:Humans; D006949:Hyperlipidemias / Q000201:enzymology / Q000235:genetics*; D008099:Liver / Q000201:enzymology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009928:Organ Specificity; D011973:Receptors, LDL / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D002785:Sterol O-Acyltransferase / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D014973:Xanthomatosis / Q000201:enzymology* / Q000235:genetics
chemical_list: D001057:Apolipoproteins E; D011973:Receptors, LDL; D002785:Sterol O-Acyltransferase